HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

S Shad Selected Research

Pathologic Complete Response

1/2022Treatment Efficacy Score-continuous residual cancer burden-based metric to compare neoadjuvant chemotherapy efficacy between randomized trial arms in breast cancer trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


S Shad Research Topics

Disease

2Residual Neoplasm
01/2022 - 01/2021
2Breast Neoplasms (Breast Cancer)
01/2022 - 01/2021
1Pathologic Complete Response
01/2022
1Neoplasms (Cancer)
01/2021
1Wound Infection (Wound Infections)
10/2006

Drug/Important Bio-Agent (IBA)

1Hormones (Hormone)IBA
01/2021
1Progesterone Receptors (Progesterone Receptor)IBA
01/2021
1taxaneIBA
01/2021
1human ERBB2 proteinIBA
01/2021
1Estrogens (Estrogen)FDA Link
01/2021
1AnthracyclinesIBA
01/2021
1Aurora Kinase AIBA
01/2021
1IceIBA
10/2006

Therapy/Procedure

1Neoadjuvant Therapy
01/2022
1Therapeutics
01/2021
1Drug Therapy (Chemotherapy)
01/2021
1Induced Heart Arrest (Cardioplegia)
10/2006